Diagnosis and prognostic markers of HCMV infection

Journal of Clinical Virology

Volumn 21, Issue 3, 2001, Pages 213-221

  Grangeot Keros, L ^a   Cointe, D ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Congenital infection; Diagnosis; HCMV infection; Immunocompromised patients; Prognostic markers

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MESSENGER RNA; VIRUS DNA;

AMNION FLUID; ANTIGEN DETECTION; CEREBROSPINAL FLUID; CONFERENCE PAPER; CONGENITAL DISORDER; CYTOMEGALOVIRUS INFECTION; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; LEUKOCYTE; MOLECULAR BIOLOGY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; SERODIAGNOSIS; TECHNIQUE; VIRUS CHARACTERIZATION; VIRUS LOAD;

BIOLOGICAL MARKERS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; PRENATAL DIAGNOSIS; PROGNOSIS;

EID: 0034992267     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(00)00164-5     Document Type: Conference Paper

References (43)

1. Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system
2. Evaluation of the Digene Hybrid Capture System for detection and quantitation of human cytomegalovirus viremia in human immunodeficiency virus-infected patients
3. Evaluation of the Murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients
4. Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients
5. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipeients by nucleic acid sequence-based amplification
6. Prenatal diagnosis of human cytomegalovirus by culture and polymerase chain reaction: 98 pregnancies leading to congenital infection
7. Quantitation of cytomegalovirus: methodologic aspects and clinical applications
8. Evaluation of the Amplicor cytomegalovirus test with specimen from human immunodeficiency virus-infected subjects
9. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection
10. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype Amplicor CMV Monitor test in transplant recipients
11. Quantification of cytomegalovirus DNA in peripheral blood leucocytes by a branched-DNA signal amplification assay
12. Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients
13. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification
14. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients
15. Human cytomegalovirus glycoprotein B genotypes in blood of AIDS patients: lack of association with either the viral DNA load in leukocytes or presence of retinitis
16. Comparison of standard tube and shell vial culture techniques for the detection of cytomegalovirus in clinical specimens
17. Value of cytomegalovirus (CMV) IgG avidity for the diagnosis of primary CMV infection in pregnant women
18. Molecular fine-specificity analysis of antibody response to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays
19. Rapid cytomegalovirus pp65 antigenemia assay by direct lyssis and immunofluorescence staining
20. Development of a method for direct quantification of cytomegalovirus antigenemia by flow cytometry
21. Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation
22. Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects
23. Prenatal diagnosis of congenital human cytomegalovirus infection
24. Anticytomegalovirus (anti-CMV) immunoglobin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection
25. Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection
26. Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients
27. Immunoglobulin M to the membrane of uninfected fibroblasts in primary human cytomegalovirus infections
28. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy
29. Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction
30. Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses
31. Prenatal diagnosis and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetuses
32. Association of cytomegalovirus genotype with graft rejection after liver transplantation
33. Effects of storage temperature and time on qualitative and quantitative detection of cytomegalovirus in blood specimens by shell vial culture and PCR
34. Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum
35. Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay
36. Cytomegalovirus (CMV) retinitis activity is accurately reflected by the presence and level of CMV DNA in aqueous humour and vitreous
37. Quantitative analysis of cytomegalovirus load using a real-time PCR assay
38. The cytomegalovirus antigenemia assay: a plea for standardization
39. Evaluation of a commercial PCR kit for diagnosis of cytomegalovirus infection of the central nervous system
40. Novel DNA assay for cytomegalovirus detection: comparison with conventionnal culture and pp65 antigenemia assay
41. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow transplant recipients with CMV disease